Advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathy
Jay Ramchand1, Agostina M Fava1, Michael Chetrit1
1Heart and Vascular Institute, Cleveland Clinic Miller Family Heart and Vascular Institute, Cleveland, Ohio, USA.
Insights
Hypertrophic cardiomyopathy (HCM) patients at high risk of sudden cardiac death (SCD) can benefit from implantable cardiac defibrillators (ICDs). Cardiac imaging advances help identify these patients, guiding ICD implantation and reducing risks.
Area of Science:
- Cardiology
- Genetics
- Medical Imaging
Background:
- Hypertrophic cardiomyopathy (HCM) is a prevalent inherited cardiac disease characterized by left ventricular hypertrophy.
- A subset of HCM patients face an elevated risk of sudden cardiac death (SCD) due to ventricular arrhythmias.
- Implantable cardiac defibrillators (ICDs) effectively mitigate SCD risk but carry potential complications like inappropriate shocks.
Purpose of the Study:
- To review the diagnostic role of cardiac imaging in HCM.
- To explore how specific imaging features aid in stratifying SCD risk in HCM patients.
- To guide the selection of appropriate candidates for ICD implantation.
Main Methods:
- Review of current literature on cardiac imaging in HCM.
- Analysis of imaging features associated with SCD risk.
- Evaluation of imaging's role in ICD implantation decisions.
Main Results:
- Cardiac imaging is crucial for diagnosing HCM.
- Specific imaging biomarkers correlate with increased SCD risk in HCM.
- Imaging facilitates personalized risk assessment for ICD therapy.
Conclusions:
- Advances in cardiac imaging are pivotal for risk stratification in HCM.
- Imaging-guided approaches can optimize ICD implantation for SCD prevention.
- Personalized risk assessment using cardiac imaging is essential for managing HCM patients at risk of SCD.
Abstract:
Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac condition, which typically manifests as left ventricular hypertrophy. A small subset of patients with HCM have an increased risk of sudden cardiac death (SCD) from ventricular arrhythmias. Risk of SCD can be effectively reduced following implantation of implantable cardiac defibrillators (ICD), although this treatment carries a risk of complications such as inappropriate shocks. With this in mind, we turn to advances in cardiac imaging to guide risk stratification for SCD and to select the appropriate individual who may benefit from ICD implantation. In this review, we have taken the opportunity to briefly summarise the role of imaging in the diagnosis of HCM before focusing on how specific imaging features influence risk of SCD in patients with HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System V: CT
Dysrhythmias V: Evaluating Dysrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests


